Log In
Print
BCIQ
Print
Print this Print this
 

solitomab (formerly MT110)

Also known as: formerly anti-Ep-CAM BiTE

  Manage Alerts
Collapse Summary General Information
Company Amgen Inc.
DescriptionBispecific T cell engager (BiTE) antibody targeting the epithelial cell adhesion molecule (EpCAM) antigen
Molecular Target Epithelial cell adhesion molecule (EpCAM)
Mechanism of ActionBinds epithelial cell adhesion molecule (EpCAM)
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase I
Standard IndicationSolid tumors
Indication DetailsTreat advanced solid tumors
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today